Introduction: We evaluated whether nephron sparing surgery (NSS) combined with meticulous suturing of the cut stump under clamping with cooling is beneficial for oncological outcomes and also assessed the relationship between cold ischemia time and deterioration of renal function. Methods: One hundred and six patients with renal cell carcinoma (RCC) were subjected to this procedure. Oncological outcomes and renal function according to the estimated glomerular filtration rate (eGFR) and the tubular excretion rate on renoscintigraphy before and at 12 months after surgery were evaluated. Results: Cancer recurrences were observed in 2 patients with past history of RCC; however, no patient died of cancer. Renal function was evaluated depending on 4 different ischemia times. All groups did not show a remarkable decrease of renal function in terms of eGFR. Renoscintigraphy revealed the deterioration of the affected kidney in patients with >60 min ischemia. Conclusion: The renoprotective procedure of NSS provided maximum preservation of renal function until 60 min of cold ischemia time.

Keywords:
Renal cell carcinoma, Nephron-sparing surgery, Cold ischemia time, Renal function, Ultrasonic scalpel
1.
MacLennan S, Imamura M, Lapitan MC, et al: Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 2012;61:972-993.
2.
Van Poppel H: Efficacy and safety of nephron-sparing surgery. Int J Urol 2010;17:314-326.
3.
Zini L, Perrotte P, Capitanio U, et al: Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer 2009;115:1465-1471.
4.
Volpe A, Blute ML, Ficarra V, et al: Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol 2015;68:61-74.
5.
Becker F, Van Poppel H, Hakenberg OW, et al: Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol 2009;56:625-634.
6.
Thompson RH, Frank I, Lohse CM, et al: The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. J Urol 2007;177:471-476.
7.
Lane BR, Russo P, Uzzo RG, et al: Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol 2011;185:421-427.
8.
Yossepowitch O, Eggener SE, Serio A, et al: Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function. J Urol 2006;176(4 pt 1):1339-1343; discussion 1343.
9.
Iida S, Kondo T, Amano H, et al: Minimal effect of cold ischemia time on progression to late-stage chronic kidney disease observed long term after partial nephrectomy. Urology 2008;72:1083-1088; discussion 1088-1089.
10.
Marberger M: Renal ischaemia: not a problem in laparoscopic partial nephrectomy? BJU Int 2007;99:3-4.
11.
Marszalek M, Meixl H, Pitzler C, et al: Periarterial papaverine improves early postoperative renal function after retroperitoneoscopic partial nephrectomy. World J Urol 2013;31:829-833.
12.
Nicholson ML, Baker DM, Hopkinson BR, et al: Randomized controlled trial of the effect of mannitol on renal reperfusion injury during aortic aneurysm surgery. Br J Surg 1996;83:1230-1233.
13.
Watanabe N, Takahashi K, Komatani A, et al: [Improved the accuracy of 99mTc-MAG3 plasma clearance method: the problem of the calculated plasma volume and its modification]. Kaku Igaku 1998;35:741-747.
14.
Watanabe N, Takahashi K, Sugai Y, et al: [The calculated reference value of the tubular extraction rate in infants and children: an attempt to use a new regression equation]. Kaku Igaku 1999;36:409-417.
15.
Majima T, Hattori R, Funahashi Y, et al: (99m)Tc-mercaptoacetyl triglycine renography to monitor renal transplant function among kidneys from donors after cardiac death. Transplant Proc 2012;44:49-53.
16.
Kanamaru H, Yamamoto M, Nagahama K, et al: Mercaptoacetyltriglycine-3 renogram is not superior to estimated glomerular filtration rate measurement for the prediction of long-term renal function after nephrectomy. Int J Urol 2011;18:570-574.
17.
Kanda Y: Investigation of the freely available easy-to-use software ‘EZR' for medical statistics. Bone Marrow Transplant 2013;48:452-458.
18.
MacLennan S, Imamura M, Lapitan MC, et al: Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol 2012;62:1097-1117.
19.
Capitanio U, Terrone C, Antonelli A, et al: Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol 2015;67:683-689.
20.
Kutikov A, Uzzo RG: The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009;182:844-853.
21.
McCarus SD: Physiologic mechanism of the ultrasonically activated scalpel. J Am Assoc Gynecol Laparosc 1996;3:601-608.
22.
Tomita Y, Koike H, Takahashi K, et al: Use of the harmonic scalpel for nephron sparing surgery in renal cell carcinoma. J Urol 1998;159:2063-2064.
23.
Ward JP: Determination of the optimum temperature for regional renal hypothermia during temporary renal ischaemia. Br J Urol 1975;47:17-24.
24.
Henriksen JH, Petersen HK: Renal blood flow and metabolism after cold ischaemia: peroperative measurements in patients with calculi. Clin Physiol 1984;4:41-50.
25.
Gill IS, Kavoussi LR, Lane BR, et al: Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007;178:41-46.
26.
Peyronnet B, Baumert H, Mathieu R, et al: Early unclamping technique during robot-assisted laparoscopic partial nephrectomy can minimise warm ischaemia without increasing morbidity. BJU Int 2014;114:741-747.
27.
Couapel JP, Bensalah K, Bernhard JC, et al: Is there a volume-outcome relationship for partial nephrectomy? World J Urol 2014;32:1323-1329.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.